Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model

Cheng, X; Zhang, YX; Zhu, M; Sun, RX; Liu, LL; Li, XL

Li, XL (通讯作者),Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Peoples R China.;Zhu, M; Li, XL (通讯作者),Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Peoples R China.;Li, XL (通讯作者),Anhui Med Univ, Sch Biomed Engn, Hefei 230032, Peoples R China.;Zhu, M (通讯作者),Tongling Univ, Sch Math & Comp Sci, Tongling, Peoples R China.

BMC MEDICAL IMAGING, 2023; 23 (1):

Abstract

Background Radical concurrent chemoradiotherapy (CCRT) is frequently used as the first-line treatment for patients with locally advanced esophageal ca......

Full Text Link